Inactive Instrument

Pharmally International Holding Company Limited Stock

Equities

6452

KYG7060F1019

Pharmaceuticals

Dynamic Chart
Pharmally International Holding Company Limited(TSEC:6452) dropped from S&P Global BMI Index CI
Pharmally International Holding Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
Pharmally International Holding Company Limited Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Pharmally International Holding Company Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019 CI
Pharmally International Holding Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
Pharmally International Holding Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2019 CI
Pharmally International Holding Co Ltd Reports Earnings Results for the Full Year Ended December 31, 2018 CI
Pharmally International Holding Company Limited announced that it has received TWD 1.17 billion in funding CI
Pharmally International Holding Company Limited completed the acquisition of PT. Biotis Prima Agrisindo. CI
Pharmally International Holding Company Limited agreed to acquire PT. Biotis Prima Agrisindo for zero consideration. CI
Pharmally International Holding Company Limited(TSEC:6452) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index CI
Pharmally International Holding Company Limited(TSEC:6452) added to S&P Global BMI Index CI
Pharmally International Holding Company Limited's Equity Buyback announced on May 13, 2015 has expired. CI
Pharmally International Holding Company Limited(TSEC:6452) added to Russell Global Index CI
Pharmally International Holding Company Limited(TSEC:6452) added to Taiwan TAIEX Index CI
More news
Managers TitleAgeSince
Chief Executive Officer - 13-12-31
Director of Finance/CFO - 13-12-31
Chairman 62 13-11-06
Members of the board TitleAgeSince
Director/Board Member - 14-07-27
Chairman 62 13-11-06
Director/Board Member - 13-11-06
More insiders
Pharmally International Holding Co Ltd is a Taiwan-based company primarily engaged in the production and sale of large volume injection and active pharmaceutical ingredients. It primarily produces large volume injection, including glass bottles, plastic bottles and non-polyvinyl chloride soft bags, and active pharmaceutical ingredients, such as nikethamide and levofloxacin lactate. It products sites are based in Mainland China.
More about the company